Xconomy National

Archives

by in

Entry	Author	Date	Location
Radius Health Seeks $86M IPO	Arlene Weintraub	02/07/12	Boston
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships	Arlene Weintraub	11/15/11	New York
Sequenom Plans $19M Lab in North Carolina, Illumina Shares Plunge, PatientSafe Advances Device, & More San Diego Life Sciences News	Bruce V. Bigelow	10/13/11	San Diego
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News	Erin Kutz	05/27/11	Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing	Arlene Weintraub	05/24/11	Boston
Ariad Extends Licenses, Amgen Osteoporosis Drug Meets Trial Goals, Corindus Partners with Philips, & More Boston-Area Life Sciences News	Erin Kutz	04/22/11	Boston
Amgen Passes Key Trial With “Son of Dmab” For Osteoporosis	Luke Timmerman	04/21/11	National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised	Luke Timmerman	03/14/11	National
From the Caves of Michigan’s Sleeping Bears Comes Kalamazoo’s Aursos, and a Possible New Drug for Osteoporosis	Howard Lovy	01/27/11	Detroit
Aursos Raises $40K for Osteoporosis Treatment	Howard Lovy	01/03/11	Detroit
Amgen Gets FDA Approval, SonoSite’s New Frontier, Craig Venter’s Enabler, & More Seattle-Area Life Sciences News	Luke Timmerman	06/03/10	Seattle
Amgen’s Dmab Wins FDA Approval	Luke Timmerman	06/01/10	Seattle
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News	Luke Timmerman	10/22/09	Seattle
Amgen’s Dmab Faces FDA Delay	Luke Timmerman	10/19/09	Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent	Luke Timmerman	10/09/09	National
Amgen’s Dmab Works in Cancer Trial	Luke Timmerman	07/07/09	Seattle
Soteira Snags $6.6M in Equity Round	Ryan McBride	05/08/09	Boston
Amgen Cuts 100 Jobs in Bothell	Luke Timmerman	04/09/09	Seattle
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News	Gregory T. Huang	04/07/09	Seattle
MDRNA Sells Osteoporosis Drug	Luke Timmerman	04/01/09	Seattle
Amgen Seeks FDA Nod For Bone Drug	Luke Timmerman	12/19/08	Seattle
MDRNA Gets Tentative FDA Approval	Luke Timmerman	12/15/08	Seattle
Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividends	Luke Timmerman	10/29/08	Seattle
Amgen’s Dmab Cuts Fracture Risk for Osteoporosis Patients, Just What Investors Wanted to See	Luke Timmerman	09/16/08	Seattle
Amgen Osteoporosis Drug Reduces Bone Fractures in Pivotal Study	Luke Timmerman	07/25/08	Seattle
Page 1 of 1